Publication Title
International Journal of Women's Health
Document Type
Article
Publication Date
12-16-2025
Abstract
Premature ovarian insufficiency (POI) is a common late effect of chemotherapy among survivors of adolescent and young-adult cancer (AYAC). Given on the widespread use of Chinese herbal medicine (CHM) in restoring individual health, we performed a cohort-based nested patient-control study with the aim of exploring the effect of blending CHM into routine care on the reduction of chemotherapy-induced POIrisk among females with AYAC.
Rights
Copyright (c) 2025 The Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
DOI
10.2147/IJWH.S541702
Persistent Identifier
https://archives.pdx.edu/ds/psu/44423
Publisher
Informa UK Limited
Citation Details
Tseng, T.-N., Liao, H.-H., Livneh, H., Lu, M.-C., Li, S.-C., & Tsai, T.-Y. (2025). Mitigating Risk of Premature Ovarian Insufficiency Using Adjunct Chinese Herbal Medicines: A Nested Patient-Control Study in Female Cancer Patients with Chemotherapy. International Journal of Women’s Health, Volume 17, 5521–5531. https://doi.org/10.2147/ijwh.s541702